Immunotherapy Avoids Surgery: MMR-Deficient Tumors Respond
The Dawn of Organ-Preserving Cancer Treatment: A Glimpse into Tomorrow The landscape of cancer treatment is rapidly evolving. Groundbreaking research, like the phase 2 trial highlighting the potential of neoadjuvant dostarlimab, is rewriting the rules and offering hope for a future where surgery becomes less of a necessity for many patients. This article delves into … Read more